UNSPSC 51111704: Mitomycin

This classification denotes an alkylating agent, antibiotics, antineoplastic, cross-linking reagent, and nucleic acid synthesis inhibitor with the molecular formula C15H18N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50SG953SK6, chemically known as 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2,3:3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester) but generally known as mitomycin, which bears US NIH Compound Identifier 5746.

UNSPSC 51111704 Mitomycin, a Commodity code, covers the procurement of mitomycin, a chemotherapy agent used in oncology and ophthalmology treatments that state and local governments acquire primarily through health systems, hospital networks, and correctional-facility medical departments. The code captures purchases of this injectable antitumor antibiotic, which is administered in clinical settings for cancer treatment and, in ophthalmic formulations, for corneal scar prevention during eye surgery. Issuing bodies under this code include state health departments, county hospital systems, municipal medical facilities, and state departments of corrections that operate inpatient and outpatient cancer programs. School districts and transit authorities do not typically procure this commodity.

The source provides no recent state or local contract opportunities under UNSPSC 51111704. Without posted RFP, RFQ, IFB, or ITB notices naming this code, geographic distribution and representative solicitations cannot be characterized from current market activity.